로딩 중…
지수 로딩 중…
Spyre Therapeutics, Inc.
SYRE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$88.34+0.97%
2026-06-18
Price Chart
Spyre Therapeutics, Inc.+485.81%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $7.67B |
| Revenue | $90M |
| Net Income | $-179M |
| Total Assets | $764M |
| Net Assets | $671M |
| Value | |
| P/B | 11.44x |
| P/S | 84.77x |
| FCF Yield | -2.42% |
| Profitability | |
| ROE | -26.75% |
| ROA | -23.49% |
| Op. Margin | -255.97% |
| Financial Health | |
| Debt Ratio | 13.88% |
| Total Debt | $0.00 |
| FCF | $-186M |
| Cash | $97M |
| Current Ratio | 8.97x |
| Performance | |
| 1Y Return | 485.81% |
| 1M Return | 32.60% |
| From 52W High | -2.91% |
| 1Y MDD | -20.91% |
| Trading | |
| Volume | 1,965,671 shares |
| Trading Value | $174M |
| Per Share | |
| EPS | $-0.45 |
| BPS | $2.07 |